Opportunities lie in leveraging advances in molecular diagnostics and pharmacogenomics, driven by trends like genomics, global prosperity, automation, and healthcare expansion in China. Threats from ...

Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...

The Centre plans a major overhaul of India’s medical device regulatory framework by removing expiry-based licences and introducing perpetual approvals, along with standardised laboratory testing norms ...